Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -13.25%16.32B | -4.11%75.7B | -4.09%59.72B | -0.53%39.17B | -1.93%18.81B | -4.37%78.94B | 4.05%62.27B | 0.25%39.38B | 4.88%19.18B | -0.33%82.55B |
| Operating income | -13.25%16.32B | -4.11%75.7B | -4.09%59.72B | -0.53%39.17B | -1.93%18.81B | -4.37%78.94B | 4.05%62.27B | 0.25%39.38B | 4.88%19.18B | -0.33%82.55B |
| Operating expenses | 13.96%-9.89B | -4.22%-51.48B | -0.74%-39.69B | -5.27%-25.46B | 1.27%-11.5B | 6.55%-49.4B | -9.69%-39.4B | -7.49%-24.19B | -8.36%-11.65B | 4.38%-52.86B |
| Gross profit | -12.14%6.43B | -18.04%24.22B | -12.40%20.04B | -9.77%13.7B | -2.94%7.31B | -0.48%29.55B | -4.41%22.87B | -9.46%15.19B | -0.08%7.53B | 7.80%29.69B |
| Selling expenses | -1,056.64%-79.37M | 23.05%-36.52M | 36.99%-19.33M | 23.35%-13.28M | 24.20%-6.86M | -15.58%-47.45M | 15.62%-30.67M | 14.30%-17.32M | -7.01%-9.05M | 13.29%-41.06M |
| Administrative expenses | 5.27%-533.12M | -6.83%-2.86B | -2.43%-1.82B | -0.44%-1.16B | -0.92%-562.78M | -0.57%-2.68B | 2.02%-1.78B | 0.20%-1.15B | 0.04%-557.66M | -10.09%-2.66B |
| Research and development expenses | -17.22%-342.84M | 21.53%-1.92B | 0.22%-885.19M | -67.68%-523.54M | -158.45%-292.49M | -0.95%-2.44B | 14.99%-887.16M | 53.92%-312.23M | 46.13%-113.17M | -29.41%-2.42B |
| Profit from asset sales | -105.15%-679.68K | 100.62%22.85M | 160.48%29.01M | 150.18%17.8M | 328,505.93%13.19M | 192.53%11.39M | 269.17%11.14M | 135.85%7.12M | -99.87%4.02K | -37.49%3.89M |
| Revaluation surplus | -106.47%-1.71M | 200.00%6.32M | --29.04M | 5,530.44%29.86M | --26.4M | 34.43%-6.32M | --0 | 88.52%-549.92K | --0 | -117.36%-9.64M |
| -Changes in the fair value of other assets | -106.47%-1.71M | 200.00%6.32M | --29.04M | 5,530.44%29.86M | --26.4M | 34.43%-6.32M | --0 | 88.52%-549.92K | --0 | -117.36%-9.64M |
| Impairment and provision | -584.73%-639.81K | -38.72%24.58M | -87.78%17.83M | -87.52%17.67M | -99.90%131.99K | 111.99%40.11M | 345.32%145.96M | 336.11%141.62M | 71,031.41%138.52M | -121.15%-334.46M |
| -Other impairment is provision | -584.73%-639.81K | -38.72%24.58M | -87.78%17.83M | -87.52%17.67M | -99.90%131.99K | 111.99%40.11M | 345.32%145.96M | 336.11%141.62M | 71,031.41%138.52M | -121.15%-334.46M |
| Special items of operating profit | -9.05%751.08M | 21.10%4.39B | -2.01%2.79B | -15.20%1.76B | 2.35%825.85M | 24.72%3.63B | 21.04%2.84B | 24.73%2.08B | -13.48%806.89M | -7.00%2.91B |
| Operating profit | -15.42%6.03B | -15.44%22.95B | -13.32%19.52B | -13.54%13.4B | -6.18%7.13B | 3.34%27.14B | -0.80%22.51B | -3.76%15.49B | 1.24%7.6B | 3.23%26.26B |
| Financing income | 19.89%43.24M | -21.08%211.49M | -15.54%169.63M | -17.69%117.29M | -48.84%36.07M | -2.52%267.96M | 1.32%200.85M | 2.63%142.5M | -0.49%70.51M | 41.18%274.89M |
| Financing cost | 10.65%-1.15B | 13.09%-4.8B | 13.42%-3.62B | 13.10%-2.39B | 8.25%-1.29B | 4.08%-5.52B | 3.00%-4.18B | 3.06%-2.75B | -3.27%-1.41B | 10.92%-5.76B |
| Special items of earning before tax | -82.35%252.29K | 146.93%177.27M | 762.58%194.57M | 779.78%205.88M | -81.31%1.43M | -490.84%-377.73M | 60.82%-29.36M | 60.85%-30.29M | 132.69%7.65M | 56.04%-63.93M |
| Earning before tax | -14.86%4.98B | -13.99%18.6B | -12.54%16.27B | -12.67%11.32B | -7.68%5.86B | 5.34%21.63B | 1.15%18.6B | -0.82%12.96B | 2.36%6.34B | 9.79%20.53B |
| After-tax profit from continuing operations | -14.19%4.07B | -15.67%14.73B | -16.87%12.89B | -18.62%8.83B | -11.60%4.74B | 2.48%17.47B | 1.28%15.5B | -0.54%10.85B | 2.59%5.36B | 11.84%17.05B |
| Earning after tax | -14.19%4.07B | -15.67%14.73B | -16.87%12.89B | -18.62%8.83B | -11.60%4.74B | 2.48%17.47B | 1.28%15.5B | -0.54%10.85B | 2.59%5.36B | 11.84%17.05B |
| Minority profit | -22.76%1.32B | -25.10%4.97B | -21.81%4.31B | -23.04%2.88B | -2.27%1.72B | 4.89%6.63B | -1.66%5.51B | -5.34%3.74B | 0.96%1.75B | 19.77%6.32B |
| Profit attributable to shareholders | -9.33%2.74B | -9.90%9.77B | -14.14%8.58B | -16.30%5.95B | -16.15%3.02B | 1.06%10.84B | 2.98%9.99B | 2.19%7.11B | 3.40%3.6B | 7.64%10.72B |
| Basic earnings per share | -10.00%0.054 | -10.23%0.193 | -14.16%0.1698 | -16.31%0.118 | -15.49%0.06 | 1.42%0.215 | 2.97%0.1978 | 2.17%0.141 | 2.90%0.071 | 7.61%0.212 |
| Diluted earnings per share | -13.33%0.052 | -10.70%0.192 | -14.61%0.1689 | -16.31%0.118 | -15.49%0.06 | 1.42%0.215 | 2.97%0.1978 | 2.17%0.141 | 2.90%0.071 | 7.61%0.212 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.